Biotest AG banner

Biotest AG
XETRA:BIO0

Watchlist Manager
Biotest AG Logo
Biotest AG
XETRA:BIO0
Watchlist
Price: 42.8 EUR
Market Cap: €1.7B

Wall St Price Targets

BIO0 Price Targets Summary
Biotest AG

There are no price targets for BIO0.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Biotest AG Competitors:
Price Targets

Revenue
Forecast

7% / Year
Past Growth
-1% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
7% / Year
Past Growth
-1% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 8 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 1 year is -1%.

Gross Profit
Forecast

4% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
4% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Biotest AG

Operating Income
Forecast

12% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
12% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 8 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 1 year is 25%.

Pre-Tax Income
Forecast

9% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
9% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 8 years, the compound annual growth rate for Pre-Tax Income has been 9%.

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is BIO0's stock price target?
Not Available

BIO0 does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Biotest AG?
Projected CAGR
-1%

Over the last 8 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 1 year is -1%.

What is the Operating Income forecast for Biotest AG?
Projected CAGR
25%

Over the last 8 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 1 year is 25%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett